Previous research found that the 4-1BB agonist improved immune cell function and could be used as an immunotherapy.5Since studies on the frequency of 4-1BB in each cancer are still scarce, they required information of 4-1BB profiles in tumor infiltrating cells of each tumor. Here, TNFRSF9 is linked to cancer.